Jarosław Czyż

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients

Jarosław Czyż, Rafał Dziadziuszko, W. Knopińska-Postuszuy et al. · Annals of Oncology · 2004 · 55 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia

Constantine S. Tam, Stephen Opat, Shirley D’Sa et al. · Blood Advances · 2024 · 32 citations · Full text

Medicine, Hematology, Oncology +13

Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML

Hanna Janiszewska, Aneta Bąk, Katarzyna Skonieczka et al. · Leukemia Research · 2018 · 31 citations

Life Sciences, Genetics, Molecular Genetics +10

Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma

Tadeusz Kubicki, Dominik Dytfeld, David R. Barnidge et al. · Blood · 2024 · 31 citations · Full text

Life Sciences, Biochemistry, Hematology +17

Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)

Bartosz Puła, Bożena Katarzyna Budziszewska, Justyna Rybka et al. · Anticancer Research · 2018 · 11 citations · Full text

Medicine, Oncology, Pharmacotherapy +17